UL vs ULS: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

UL is the larger of the two ($138.22B market cap): the incumbent the market prices for continued execution (16.59x forward earnings, beta 0.46). ULS is the smaller challenger ($14.82B), actually pricier on forward earnings (27.78x): more room to run, but more to prove. If you believe in growth, ULS fits: analysts expect its revenue to rise 10% next year, against 5% for UL. If you believe in paying less for profit, UL fits: it trades at 16.59x forward earnings, against 27.78x for ULS.

UL vs ULS: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricULULSWhat it tells you
Market cap$138.22B$14.82BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E16.5927.78Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E12.9729.14Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.460.61Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range47% of range23% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book7.608.70How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: UL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how UL and ULS affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. UL and ULS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined UL and ULS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Unilever PLC (UL) do?

Unilever PLC is one of the world's largest consumer-goods companies, and UL is its NYSE-listed ADR (the London line trades as ULVR, with a further listing in Amsterdam). After the late-2025 demerger of its ice cream arm, Unilever is organized around four business groups: Beauty & Wellbeing (Dove, Vaseline, and premium and wellness brands), Personal Care (deodorants, skin cleansing, and oral care such as Rexona and Lifebuoy), Home Care (laundry and cleaning brands like Persil and Cif), and Foods, also called Nutrition (Knorr, Hellmann's, and cooking products). A large share of turnover now comes from a concentrated set of roughly 30 Power Brands, which the company reports have been growing faster than the overall portfolio. Because it sells low-cost, repeat-purchase essentials, Unilever tends to hold up better than cyclical businesses in downturns, though it is exposed to input-cost inflation, currency swings, and slower volume growth in developed markets.

Full UL guide

What does UL Solutions (ULS) do?

UL Solutions Inc. is a global safety-science company that traces its roots to Underwriters Laboratories, founded in 1894. It earns money by testing, inspecting and certifying products against safety and performance standards, most visibly through the UL mark found on consumer electronics, appliances, wiring and industrial equipment. The business runs across three segments: Industrial (energy, automation, engineered materials and the built environment), Consumer (electronics, medical devices, appliances, HVAC and lighting), and Software and Advisory (regulatory, supply-chain and sustainability tools). Much of the revenue is recurring, because certified products need ongoing follow-up testing to keep their marks, and the company remains majority controlled by the nonprofit UL Standards and Engagement following its April 2024 IPO.

Full ULS guide

UL vs ULS: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • UL drivers: Power Brands and premiumization; Growth Action Plan and cost discipline.
  • ULS drivers: Regulation-driven recurring demand; Electrification and new technology testing.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. For ULS, the most cited risk is valuation: even after a 2026 pullback, the stock trades near 28x forward earnings, well above the mid-teens typical of professional-services peers, so it still prices in continued strong execution and leaves limited room for disappointment.

UL or ULS: which should you pick?

If the story you believe is UL's (Power Brands and premiumization), UL is the more direct way to own it; if it is ULS's (Regulation-driven recurring demand), ULS is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the UL and ULS guides.

UL vs ULS: the full fundamentals

UL. At about 16.6x forward earnings and a yield near 3.3%, UL is priced as a steady staple, not a turnaround that has already worked. The trailing P/E of ~13.0x looks cheaper than it is because 2025 earnings include gains tied to the ice cream separation, so the forward multiple is the cleaner read; EV/EBITDA is about 15. Results are reported in euros, so currency moves change the dollar figures, including the dividend, independent of how the business performs.

ULS. The multiple has come down a long way from the low 50s trailing P/E the stock carried in early 2026: the share price fell and trailing earnings rose, partly on a large one-time-looking June quarter. At about 28x forward earnings and roughly 20.6x EV/EBITDA, ULS is still priced above TIC peers, which leaves the stock sensitive to how the Eurofins and Worldly businesses integrate. Consensus expects 2027 revenue of about $3.62 billion, roughly 11% growth, and EPS of about $2.64; twelve analysts have a mean target near $96.45.

Headline figures (approximate, November 2026): UL shows share price and market cap ~$64.28 per ADR (Nov 20, 2026); market cap ~$138 billion; 52-week range ~$54.75-74.98, revenue (ttm) ~EUR 50.6 billion, after removing ice cream (2024 turnover was ~EUR 60.8 billion), revenue growth (latest reported quarter) ~+0.5% year on year; Q2 2026 turnover ~EUR 13.05 billion, margins Gross ~47%, operating ~20%, net ~18%; ULS shows revenue (ttm) ~$3.19B (FY2025: ~$3.05B), revenue growth (latest quarter) ~5.1% year on year; Q3 2026 revenue ~$823M, margins Gross ~51%, operating ~19%, net ~16%, net income (ttm) ~$514M, boosted by an unusually large ~$246M June quarter.

The bottom line: UL vs ULS

UL and ULS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined UL and ULS exposure against your real portfolio. It is not an investment adviser.

Wondering how UL or ULS fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Unilever PLC

Ask Walnut's AI anything about UL and see how it fits what you own.

FAQ

What is the difference between UL and ULS?

+

Unilever PLC is one of the world's largest consumer-goods companies, and UL is its NYSE-listed ADR (the London line trades as ULVR, with a further listing in Amsterdam). UL Solutions Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is UL or ULS the better stock?

+

Neither is universally better. UL is the larger incumbent; ULS is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, UL or ULS?

+

On forward P/E (as of November 2026), UL trades at 16.59x and ULS at 27.78x, so UL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both UL and ULS?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of UL vs ULS?

+

UL: The main risk is that a slow-growth staples business trades on the credibility of its turnaround: if the Growth Action Plan does not lift volumes and margins as hoped, the stock can languish. Input-cost inflation in commodities and packaging can squeeze margins, and heavy price increases risk losing volume to private label and cheaper rivals. As an ADR, UL results are reported in euros, so a stronger dollar reduces the dollar value of sales, earnings, and the dividend for US holders. Execution risk is real: management overhauls, thousands of role changes, and integrating the shift to a category-led model can distract the organization. The retained minority stake in The Magnum Ice Cream Company is an overhang the company plans to sell down, and some brands (such as Ben & Jerry's, now part of the demerged entity) have a history of activism-related controversy. Slower developed-market volumes and intense competition round out the picture. Debt is a further point to watch: Unilever carries about EUR 32 billion of debt against roughly EUR 6 billion of cash, manageable for a business generating about EUR 6.7 billion of free cash flow a year but a constraint on how fast it can buy growth. Consensus also expects forward earnings per share to come in well below the trailing figure, which was flattered by the ice cream demerger, so the trailing P/E of about 13 understates what buyers pay for ongoing earnings. ULS: The most cited risk is valuation: even after a 2026 pullback, the stock trades near 28x forward earnings, well above the mid-teens typical of professional-services peers, so it still prices in continued strong execution and leaves limited room for disappointment. The 52-week swing between roughly $63 and $108 shows how quickly that premium can move. Growth is only mid-single-digit organically, so testing volumes are exposed to industrial and consumer demand cycles, and softness in manufacturing or new-product launches could weigh on results. China exposure, tariff and trade shifts, and currency swings add uncertainty, as the company flags in its filings. Acquisition integration carries execution risk, now across two deals: Eurofins, closed in October, and Worldly, which is funded partly with about $127 million of new Class A stock plus cash and the revolving credit facility. To offset that issuance, ULS agreed to buy back about 1.64 million Class B shares from UL Standards and Engagement for about $130 million. The nonprofit retains voting control, limiting public shareholders' influence. The September quarter, when EPS only matched consensus, showed growth is running at about 5%. Any margin stall or slowdown could compress the premium multiple quickly.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell UL or ULS; figures are approximate and dated (as of November 2026). Verify current data before investing.